Compass Point has initiated coverage on Circle Internet Group Inc . (NYSE:CRCL) with a “neutral” rating and a $205 price target, citing both its leadership in regulated stablecoins and challenges in ...

USDC stablecoin issuer Circle stumbled Tuesday morning as Compass Point intitiated coverage with a neutral rating.

Compass Pathways' Phase 3 COMP-360 data met primary endpoints but disappointed vs analyst expectations. See why investors ...

While positive, results from a late-stage clinical trial appear to be raising questions about how useful the company’s ...

The move comes after months of increasingly aggressive maneuvers by Zillow to stop Compass from promoting and expanding its ...

Compass Pathways plc downgraded to Hold after mixed trial results. Explore upcoming catalysts in depression treatment and ...

Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.

Compass Pathways Plc’s shares plummeted after its psychedelic drug to treat a form of depression disappointed investors in a ...

Circle Internet (NYSE:CRCL) operates a blockchain-based platform that enables stablecoin issuance, tokenized assets, and ...

Compass Pathways' COMP005 trial met its primary endpoint in TRD, but modest results sparked a 47% drop in shares amid ...

Compass Pathways' psilocybin-based depression therapy reduced the severity of symptoms in a closely watched study, but shares of the biotech firm plunged more than 46% to a record low on Monday as the ...